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To the Editor: Members of 
the genus Rickettsia have garnered 
much attention worldwide in recent 
years with the emergence of newly 
recognized rickettsioses. In New 
Zealand, only Rickettsia typhi and 
R. felis, belonging to the typhus and 
spotted fever groups, respectively, 
have so far been found (1). R. typhi, 
primarily transmitted by the oriental 
rat fl ea (Xenopsylla cheopis), has a 
worldwide distribution and causes 
murine typhus in humans (2). At the 
end of 2009, a total of 47 cases of 
murine typhus had been recorded in 
New Zealand. In contrast, although 
the cat fl ea (Ctenocephalides felis) can 
carry R. felis in New Zealand (3), no 
human infections have been reported. 
However, because R. felis shares 
a similar clinical profi le to murine 
typhus, infection can be mistaken for 
a suspected case of R. typhi (4).
Clinical suspicion of rickettsial 
infection is widely confi rmed by 
serologic tests with the indirect 
immunofl uorescence assay (IFA) being 
the standard test. However, antibodies 
against R. felis in human sera are 
known to cross-react with R. typhi in 
IFA (5). Western blot (WB) and cross-
adsorption assays, in combination with 
IFA, can differentiate between several 
rickettsioses (5,6). We report on the 
trial in New Zealand of WB and cross-
adsorption assays for differentiating 
retrospectively between past R. typhi 
and R. felis infections and evidence of 
R. felis infection in persons living in 
the country.
Serum samples were obtained 
from 24 volunteers from the Institute 
of Environmental Science and 
Research Limited, Porirua, New 
Zealand. Samples were tested using R. 
typhi IFA slides (Australian Rickettsial 
Reference Laboratory [ARRL], 
Geelong, Victoria, Australia). After 
incubation (37°C for 30 min), slides 
were washed 3 times, incubated with 
fl uorescein-conjugated antihuman 
IgG, IgM, and IgA (ARRL), and 
washed again before examination. 
All samples were then tested by using 
an IgG IFA kit (Focus Diagnostics, 
Cypress, CA, USA) against typhus 
group (TG) R. typhi and spotted fever 
group (SFG) R. rickettsii. 
TG-positive and SFG-negative 
serum samples may represent R. typhi 
infections, and SFG-positive and TG-
negative serum samples may represent 
R. felis infections. Because R. typhi can 
cross-react with SFG rickettsiae (7), 
and R. felis with R. typhi (5), results 
that are TG positive and SFG positive 
may be caused by either rickettsiae. 
Positive reactivity may also represent 
overseas-acquired rickettsioses. Thus, 
WB and cross-adsorption assays using 
R. typhi (Wilmington) and R. felis 
(URRWXCal2) antigens (Unité des 
Rickettsies, Marseilles, France) were 
used to confi rm any R. typhi or R. felis 
infections (6).
Antigens (2 mg/mL) were 
solubilized (100°C for 10 min) in 2× 
Laemmli buffer (6) and subjected 
to electrophoresis (20 μg/well; 20 
mA, 2.5 h) through polyacrylamide 
gels (12.5% resolving; 4% stacking) 
(BioRad, Hercules, CA, USA). 
Resolved antigens were electroblotted 
(100 V for 1 h) onto 0.45-μm 
polyvinylidene difl uoride membranes, 
which were blocked by using 5% 
milk–Tris-buffered saline with 0.1% 
Tween 20. Each antigen lane was 
divided into 2 strips before incubation 
(room temperature for 1 h) with 
serum (diluted 1:200). After three 
10-min washes with Tris-buffered 
saline with 0.1% Tween 20, strips 
were incubated (room temperature, 
1 h) with horseradish peroxidase–
conjugated antihuman IgG (1:150,000; 
SouthernBiotech, Birmingham, AL, 
USA) and washed again. Enhanced 
chemiluminescent detection of bound 
horseradish peroxidase (ECL Plus; 
GE Healthcare, Buckinghamshire, 
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UK) enabled identifi cation of reactive 
band sizes with Precision Plus 
standards (BioRad). Cross-adsorption 
was carried out by incubating serum 
diluted 1:30 in boiled antigen (37°C 
for 5.5 h, then 4°C overnight) before 
centrifugation (10,000 × g for 10 min) 
(6). Supernatants were applied to WB 
strips and results compared with R. 
typhi and R. felis antisera.
Of the 24 serum samples, 3 
(12.5%) were positive on the ARRL 
slides, and 11 (45.8%) showed IgG 
reactivity on Focus slides (Table). Of 
these 11 serum samples, 8 (33.3%) 
were SFG positive and TG negative, 
and 3 (12.5%) were SFG and TG 
positive. Of the 12 serum samples 
that showed some IFA reactivity, after 
cross-adsorption, none had specifi c 
reactivity against R. typhi, and 2 were 
confi rmed as R. felis. Both volunteers 
recorded risk factors associated with 
R. felis infection. Six serum samples 
were indeterminate. Detectable 
antibodies remained after both cross-
adsorptions, which may be caused 
by infection by R. felis and R. typhi, 
or other rickettsiae or cross-reactive 
pathogens (5,8).
Although IgG titers decline over 
time, detectable levels can remain 
for 4 years and thus exposure to R. 
felis may have occurred any time 
during this period (9). Because both 
R. felis–infected persons had traveled 
overseas within the past 4 years and 
R. felis has a wide distribution (4), 
overseas exposure is possible. R. felis 
is known to be prevalent in C. felis 
fl eas, including in New Zealand (3,4). 
This prevalence and the high rate of 
cat and dog ownership have public 
health implications and support the 
recognition of R. felis as an emerging 
global health threat (4). Infection from 
R. felis in addition to R. typhi should 
be considered in the differential 
diagnosis of fever, headache, myalgia, 
and rash.
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Table. Serologic data and risk factors of volunteers that showed positive reactivity in rickettsial IFA, New Zealand* 
Volunteer
no.
IFA serologic titers 
WB and cross-
adsorption results 
Risk factors in the past 4 years 
ARRL kit† Focus kit‡ 
Flea or animal contact Traveled overseasRickettsia typhi R. typhi R. rickettsii
4 Neg  64 64 Indeterminate§ Rat, cat, dog Yes 
5 Neg  Neg 64 Indeterminate Cat, dog Yes 
8 Neg  Neg 128 Neg¶ Flea, rat, cat, dog Yes 
9 Neg  Neg 64 Indeterminate Flea, cat, dog Yes 
16 Neg  Neg 128 Indeterminate Rat, cat, dog Yes 
17 Neg  Neg 128 R. felis Rat, cat, dog Yes 
18 128  64 64 Neg Cat, cow, hen Yes 
19 128  Neg 64 Indeterminate Cat, dog Yes 
21 Neg  64 256 R. felis Flea, cat, dog, possum Yes 
22 Neg  Neg 64 Neg Cat, dog Yes 
23 256  Neg Neg Neg Rat, cat, dog No 
25 Neg  Neg 128 Indeterminate None Yes 
*IFA, indirect immunofluorescence assay; ARRL, Australian Rickettsial Reference Laboratory; WB, Western blot; neg, negative. 
†The cutoff titer for seropositivity was 128 as recommended by the manufacturer. 
‡According to kit instructions, endpoint titers 64 and <256 indicate either past infection or early response to a recent infection, and 256 are considered 
presumptive evidence of recent or current infection. 
§Serum samples that still reacted with R. typhi and R. felis after cross-adsorption were classified as indeterminate responses. 
¶Serum samples that showed no specific reactions to R. typhi and R. felis in the WB assay were classified as negative for R. typhi and R. felis..
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To the Editor: During May 
and June 2011, a large outbreak of 
hemolytic uremic syndrome (HUS) 
and diarrhea caused by Shiga toxin–
producing Escherichia coli (STEC) 
occurred, centered on northern 
Germany (1,2). Early on, salads and 
raw vegetables were suspected to be 
food vehicles (3). Also in May, the 
staff department of a local company 
informed the Health Protection 
Authority in Frankfurt in southwestern 
Germany about the rapidly increasing 
number of patients with bloody 
diarrhea and HUS among employees at 
2 company offi ce sites. Both sites were 
served by cafeterias run by the same 
caterer. Main dishes were prepared in 
the cafeterias’ kitchens and differed 
between the 2 sites. However, in both 
cafeterias various fresh foods from a 
salad bar and fruits, desserts, and daily 
asparagus dishes originated from 
the caterer’s main kitchen. The salad 
bar included 30 items. Suspecting 
that this outbreak was linked to 
the one in northern Germany, we 
conducted an outbreak investigation 
to confi rm the epidemiologic link to 
focus epidemiologic and traceback 
investigations.
A face-to-face survey among 
hospitalized employees and by email 
among all other employees was 
conducted, which included personal 
details, symptoms, and information 
about general food eaten at the 
cafeterias. We defi ned outbreak cases 
as infections in employees of the 
company at 1 of the 2 sites who by 
May 23, 2011, were either hospitalized 
with bloody diarrhea or HUS or 
who self-reported onset of bloody 
diarrhea from May 8 through May 
23. A total of 320 persons responded 
to the survey, and 285 (89%) of 320 
of the responders stated they used the 
cafeterias; 60 employees fulfi lled our 
case defi nition. Case-patients’ median 
age was 33 years (range 22–60 years), 
and 36 (60%) of 60 were female. 
Thirty case-patients were hospitalized; 
HUS developed in 18 (30%) (online 
Appendix Figure, wwwnc.cdc.gov/
EID/article/18/1/11-1044-FA1.htm). 
Disease onsets occurred over 9 days. 
Beginning and magnitude of the 
outbreak were not different between 
cafeteria locations. Bacteriologic 
diagnostics for 11 patients yielded 
results that are compatible with the 
outbreak strain (4).
We used billing data from the 
cafeterias’ obligatory cashless payment 
system to ascertain risk factors for 
disease. A nested case–control study 
design was chosen, limited to a fraction 
of the cohort to obtain rapid risk 
estimates. Exposures included were 
purchases of any fruit, salad bar item, 
dessert, or asparagus dish in either 
cafeteria from May 2 through May 13. 
On the basis of customer identifi cation 
numbers, the caterer provided billing 
information for persons with early 
cases (n = 23). Controls were randomly 
chosen persons from the caterer’s 
database whose disease status was 
checked against the survey information 
(n = 30) and who did not report 
symptoms of diarrhea (nonbloody), 
vomiting, or nausea during the same 
period. Univariable logistic regression 
was performed.
In univariable analysis, salad 
bar purchases were highly associated 
with illness (odds ratio 5.19; 95% CI 
1.28–21.03), and desserts, fruit, and 
asparagus dishes were not (Table). 
Three (9%) of the case-patients 
remained unexposed to salad bar items 
according to the payment system 
data. The analysis of main courses 
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Table. Univariable analysis of risk factors for bloody diarrhea among users of 2 cafeterias in Frankfurt, Germany, 2011 
Risk factor 
No. case-patients exposed/ 
total no. (%) 
No. controls exposed/ 
total no. (%) 
Univariable analysis* 
Odds ratio (95% CI) p value 
Salad bar 20/23 (87) 16/30 (53) 5.83 (1.42–23.88) 0.014 
Dessert 16/23 (70) 18/30 (60) 1.52 (0.48–4.81) 0.473 
Fruits 5/23 (22) 10/30 (33) 0.53 (0.15–1.81) 0.312 
Asparagus dish 7/23 (30) 11/30 (37) 0.76 (0.24–2.41) 0.635 
Female sex 16/23 (70) 15/30 (50) 2.28 (0.73–7.15) 0.155 
Age, y 
 <30 12/23 (52) 6/30 (20) 2.80 (0.62–12.66) 0.181 
 30–<40 5/23 (22) 7/30 (23) Reference Reference 
 40–<50 4/23 (17) 13/30 (43) 0.43 (0.09–2.14) 0.303 
>50 2/23 (9) 4/30 (13) 0.70 (0.09–5.43) 0.733 
*Estimates in a multivariable model remained virtually unchanged. 
